Epidemiology & Risk Factors

Etiology divided into Immune (10–15%) and Non-Immune (85–90%).
Immune Hydrops:
- Maternal-fetal blood group incompatibility: Rh alloimmunization (anti-D antibodies), anti-Kell, anti-E.
Non-Immune Hydrops:
- Cardiovascular (~40%, most common non-immune cause): Congenital heart disease, structural malformations, arrhythmias (e.g., fetal SVT).
- Chromosomal/Genetic: Turner syndrome (45,X) (associated w/ cystic hygroma), Trisomy 21, 18, 13.
- Hematologic: Alpha-thalassemia major (Hb Barts: 4-gene deletion --/--), G6PD deficiency, hereditary spherocytosis.
- Infections: Parvovirus B19 (viral destruction of erythroid progenitor cells -> severe fetal anemia), CMV, Toxoplasmosis, Syphilis. c
- Twin-to-Twin Transfusion Syndrome (TTTS): Severe volume overload in recipient twin.

Clinical Features

Definition: Excess fluid accumulation in ≥2 fetal body compartments. c
Fetal Ultrasound Findings:
- Ascites, pleural effusion, pericardial effusion, scalp edema / generalized skin edema (>5 mm).
- Polyhydramnios (impaired fetal swallowing/fluid clearance).
- Placentomegaly (placental thickness >4 cm).
Fetal Heart Rate Tracing:
- Sinusoidal FHR pattern (indicates severe, life-threatening fetal anemia).
Maternal Manifestations:
- Mirror syndrome (Ballantyne syndrome): Maternal development of preeclampsia-like symptoms (generalized edema, HTN, proteinuria) mirroring fetal hydrops condition.

Initial/Screening (Prenatal US):
- Diagnostic confirmation by detecting fluid accumulation in ≥2 body cavities on US.
- Middle Cerebral Artery Peak Systolic Velocity (MCA-PSV): Non-invasive Doppler screening for fetal anemia (MCA-PSV >1.5 MoM indicates severe anemia).
Maternal Diagnostic Workup:
- ABO/Rh typing, Indirect Coombs test (antibody titer; ≥1:16 for anti-D is critical threshold).
- Kleihauer-Betke (KB) test: Quantifies fetomaternal hemorrhage.
- Maternal serologies: TORCH panel, Parvovirus B19 IgM/IgG/PCR.
Confirmatory / Gold Standard:
- Percutaneous Umbilical Blood Sampling (PUBS / Cordocentesis): Direct sampling of fetal blood for Hb/Hct, blood group, Direct Coombs test, blood gas analysis. Enables immediate therapy.
- Amniocentesis / CVS: Karyotype, chromosomal microarray, infection PCR.

Isolated Fetal Ascites / Pleural Effusion:
- Fluid in only 1 fetal compartment; does not fulfill criteria for hydrops fetalis (requires ≥2).
Cystic Hygroma:
- Localized nuchal lymphatic malformation (commonly 45,X); can progress to hydrops, but initial disease is limited to nuchal tissue.
Congenital Heart Failure w/o Hydrops:
- Cardiomegaly and high cardiac output state on fetal echocardiogram w/o fluid extravasation into multiple body cavities.

Immediate Stabilization & Etiology-Based Interventions:
- Severe Fetal Anemia (Rh alloimmunization, Parvovirus B19):
  - Intrauterine Transfusion (IUT): Access umbilical vein via PUBS to deliver O-negative PRBCs if GA <34 weeks.
- Fetal Arrhythmia (e.g., SVT):
  - Transplacental antiarrhythmic administration to mother (e.g., Digoxin, Flecainide, Sotalol).
Prevention (Rh Incompatibility):
- Anti-D Immune Globulin (RhoGAM): Administered to nonsensitized Rh-negative mothers at 28 weeks GA and within 72 hrs post-delivery, miscarriages, or invasive procedures.
Timing & Mode of Delivery:
- If GA ≥34 weeks or fetal pulmonary maturity confirmed: Immediate delivery.
- Urgent C-section for Category III FHR tracing (e.g., sinusoidal FHR pattern) or severe fetal decompensation.
Postnatal Resuscitation:
- Immediate endotracheal intubation.
- Emergent thoracentesis and/or paracentesis to decompress cavities and allow lung expansion.

Fetal/Neonatal:
- Pulmonary hypoplasia (compression from pleural effusion/ascites).
- High cardiac output heart failure.
- Intrauterine Fetal Demise (IUFT) or severe neonatal asphyxia (mortality >50%).
Maternal:
- Mirror syndrome: Life-threatening maternal disease; requires treatment of fetal cause or prompt delivery.
- Postpartum hemorrhage (secondary to severe uterine overdistension from polyhydramnios).

tags	—
aliases